We are live on ! Find out more
DGX icon

Quest Diagnostics
DGX

895 hedge funds and large institutions have $15B invested in Quest Diagnostics in 2024 Q4 according to their latest regulatory filings, with 124 funds opening new positions, 313 increasing their positions, 300 reducing their positions, and 59 closing their positions.

New
Increased
Maintained
Reduced
Closed

110% more first-time investments, than exits

New positions opened: 124 | Existing positions closed: 59

81% more call options, than puts

Call options by funds: $63.1M | Put options by funds: $35M

6% more funds holding

Funds holding: 846 → 895 (+49)

1.22% more ownership

Funds ownership: 87.82% → 89.04% (+1.2%)

4% more repeat investments, than reductions

Existing positions increased: 313 | Existing positions reduced: 300

1% less capital invested

Capital invested by funds: $15.2B → $15B (-$172M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
895
Holders Change
+49
Holders Change %
+5.79%
% of All Funds
11.79%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
124
Increased
313
Reduced
300
Closed
59
Calls
$63.1M
Puts
$35M
Net Calls
+$28.2M
Net Calls Change
+$22.3M

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$255M
2
JP Morgan Chase
JP Morgan Chase
New York
+$143M
3
UBS Group
UBS Group
Switzerland
+$91.5M
4
AllianceBernstein
AllianceBernstein
Tennessee
+$77.5M
5
Millennium Management
Millennium Management
New York
+$76.4M

Top Sellers

1
American Century Companies
American Century Companies
Missouri
-$119M
2
Citadel Advisors
Citadel Advisors
Florida
-$116M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$85.4M
4
Goldman Sachs
Goldman Sachs
New York
-$64.9M
5
Invesco
Invesco
Georgia
-$44.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
SIC
851
SJS Investment Consulting
Ohio
$3.19K -$156 -1 -5%
CIAM
852
Caitong International Asset Management
Hong Kong
$3.17K +$3.27K +21 New
RS
853
Rakuten Securities
Japan
$3.02K +$3.11K +20 New
GFPC
854
Global Financial Private Client
Florida
$2.87K +$778 +5 +36%
DPW
855
DiNuzzo Private Wealth
Pennsylvania
$2.72K – – –
SL
856
Salomon & Ludwin
Virginia
$2.71K – – –
LSA
857
Leonteq Securities AG
Switzerland
$2.56K -$1.24K -8 -32%
CWP
858
Concord Wealth Partners
Virginia
$2.41K – – –
ATC
859
Adirondack Trust Company
New York
$2.41K – – –
CPG
860
Cornerstone Planning Group
New Jersey
$2.4K +$2.33K +15 New
CWC
861
Carolinas Wealth Consulting
North Carolina
$2.26K -$26.4K -170 -92%
JFA
862
JNBA Financial Advisors
Minnesota
$2.26K – – –
GBT
863
Grove Bank & Trust
Florida
$2.26K +$2.33K +15 New
WA
864
Whipplewood Advisors
Colorado
$2.26K +$2.33K +15 New
VWA
865
Valued Wealth Advisors
Utah
$2.11K – – –
FGC
866
Financial Gravity Companies
Texas
$2.11K – – –
BFPW
867
BOK Financial Private Wealth
Colorado
$1.96K +$467 +3 +30%
BWAM
868
Boyd Watterson Asset Management
Ohio
$1.96K – – –
CAM
869
Creekmur Asset Management
Illinois
$1.96K +$2.02K +13 New
HWA
870
HHM Wealth Advisors
Tennessee
$1.66K +$1.71K +11 New
AP
871
Aspect Partners
Virginia
$1.66K – – –
CSWM
872
Cassady Schiller Wealth Management
Ohio
$1.66K +$1.71K +11 New
NC
873
NewSquare Capital
Pennsylvania
$1.66K +$1.71K +11 New
JGIA
874
Jackson Grant Investment Advisers
Connecticut
$1.36K – – –
SC
875
Solstein Capital
California
$1.36K – – –
33 34
35
36 37

DGX Hedge Fund Activity: Q4 2024 in Review

895 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q4 2024, worth a combined $15B — down 1.1% from $15.2B a quarter earlier.

Buyers outnumbered sellers: 124 funds opened new DGX positions and 59 closed out — a net gain of 65 holders — while 313 added to existing stakes and 300 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $255M. The largest seller was American Century Companies, cutting an estimated $119M.

  • 895 institutional investors held Quest Diagnostics (DGX) as of Q4 2024, up from 846 in Q3 2024.
  • Funds reported $15B of Quest Diagnostics stock for Q4 2024, down 1.1% quarter-over-quarter.
  • 124 funds opened new Quest Diagnostics positions in Q4 2024 and 59 closed out, a net change of +65 holders.
  • The largest Quest Diagnostics buyer in Q4 2024 was T. Rowe Price Associates, an estimated $255M added.
  • The largest Quest Diagnostics seller in Q4 2024 was American Century Companies, an estimated $119M sold.

Based on aggregated 13F filings for Q4 2024.